COLORADO SPRINGS, Colo., The Spectranetics Corporation (NASDAQ:SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of its peripheral atherectomy product, the ...

Spectranetics Corporation today announced that it plans to initiate the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial ...

Please provide your email address to receive an email when new articles are posted on . The FDA issued 510(k) clearance to Spectranetics for a peripheral laser atherectomy catheter for the treatment ...

The problem of peripheral in-stent restenosis (ISR) remains a major problem for clinicians and there is currently no FDA-cleared or approved device to treat this growing patient population. There are ...

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC) today announced an agreement with ThermopeutiX, Inc. to commercialize the TAPAS catheter, a therapeutic infusion ...

Please provide your email address to receive an email when new articles are posted on . Spectranetics, which makes balloons and catheters for peripheral and coronary intervention, announced that it ...

Philips has been known for its light bulbs and in the healthcare world for its medical imaging equipment. Philips Lighting is now a separate public entity while Royal Philips, having jettisoned that ...

Healthcare technology Dutch giant Royal Philips will purchase Spectranetics, a Colorado-based company that employs vascular intervention to treat coronary and peripheral artery disease. Philips ...